Journavx Market Access Strategy in Focus: What ...

By Rene Pretorius

March 17, 2025

Vertex Pharmaceuticals’ Journavx, a non-opioid pain medication, received
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
Strategies to Control Rising Health Insurance Premiums in Singapore
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England